Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents
- PMID: 2110930
- DOI: 10.1007/BF00210801
Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents
Abstract
We have studied the effects of cocultivation on the frequency of mitomycin C (MMC)-induced chromosomal aberrations. This was carried out by cocultivating Fanconi anemia (FA) cells from the genetic complementation groups A and B with both normal mouse lymphoma L5178Y cells and the derived "FA-like" mutant cells, MCN-151 and MCE-50, assigned to complementation groups I and II, respectively. The results show a partial complementation of the defect (i.e. a reduction in the frequency of chromosomal aberration) in FA group A cells cocultured with normal or group II mouse cells, and a partial correction of mouse group I cells cocultived with normal or FA group B human cells. No reciprocal effects were observed between FA group A cells and mouse group I mutant cells; the frequencies of MMC-induced chromosomal aberrations in these cells remained unchanged by cocultivation. Moreover, no complementation was observed for both FA group B cells and mouse group II cells, after cocultivation with normal cells of either mouse or human origin. This implies that a diffusible factor released by normal human and mouse cells, and by FA group B and mouse group II mutant cells, can correct at least in part the chromosomal defect of FA group A and mouse group I mutant cells. With normal human or mouse cells, the frequency of chromosomal breakage after cocultivation remains the same as that observed in non-cocultived cells. This suggests that no detectable clastogenic factor is released by human FA or "FA-like" mouse cells.
Similar articles
-
Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.Hum Genet. 1990 Dec;86(2):151-61. doi: 10.1007/BF00197697. Hum Genet. 1990. PMID: 2265827
-
Identification of two complementation groups in Fanconi anemia.Somat Cell Mol Genet. 1985 Jan;11(1):35-41. doi: 10.1007/BF01534732. Somat Cell Mol Genet. 1985. PMID: 3919452
-
Proliferative kinetics and mitomycin C-induced chromosome damage in Fanconi's anemia lymphocytes.Hum Genet. 1983;63(1):19-23. doi: 10.1007/BF00285391. Hum Genet. 1983. PMID: 6403454
-
Fanconi's anemia: genetic and molecular aspects of the defect.Nouv Rev Fr Hematol (1978). 1990;32(6):387-9. Nouv Rev Fr Hematol (1978). 1990. PMID: 2101869 Review.
-
[Progress of research on protein composition and gene therapy of Fanconi anaemia - review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):231-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15157341 Review. Chinese.
Cited by
-
Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene.Mol Cell Biol. 1995 Jan;15(1):305-14. doi: 10.1128/MCB.15.1.305. Mol Cell Biol. 1995. PMID: 7799938 Free PMC article.
-
Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.Hum Genet. 1990 Dec;86(2):151-61. doi: 10.1007/BF00197697. Hum Genet. 1990. PMID: 2265827
-
Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6.Hum Genet. 1992 Apr;89(1):42-8. doi: 10.1007/BF00207040. Hum Genet. 1992. PMID: 1577464
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical